Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB09306ExperimentalSmall molecule
Metralindole, also known as Inkazan, is similar in structure and pharmacology to pirlindole. It functions as a reversible inhibitor of monoamine oxidase A. In Russia, this drug was investigated for...
- Primary indication
- Investigated for the treatment of depression.Curator reviewed
- Formula / weight
- C15H17N3O · 255.321 g/mol (avg)
- Also known as
- Incasan · Inkazan
Resolves to
Structure
InChIKey
GVXBHSBKKJRBMS-UHFFFAOYSA-NSMILESCOC1=CC2=C(C=C1)N1CCN(C)C3=NCCC2=C13What you can answer from here — as of August 30, 2026
Which companies are running trials of Metralindole, in which indications and phases, and which of those programs are still active?